Payne Undergoing Treatment for Low Platelet Count, Out Indefinitely
Some sad news to report regarding Wolves forward Adreian Payne – he’s been sidelined indefinitely as he undergoes treatment for thrombocytopenia, a blood disorder. From the team’s press release:
Minneapolis/St. Paul – The Minnesota Timberwolves today announced that forward Adreian Payne will be sidelined indefinitely while being treated for a condition of low platelet count (thrombocytopenia).
Payne, who is receiving care under the guidance of Wolves team physicians, is currently resting comfortably at home. Payne’s prognosis for recovery is good and he will return to the court when it is deemed safe for him to do so.
“Our primary concern is for the health of Adreian,” said President of Basketball Operations and Head Coach Tom Thibodeau. “We look forward to him rejoining the team at the appropriate time.”
Payne, who turns 26 on February 19th, is averaging 4 points and 1.7 rebounds in his 12 appearances this season. Originally drafted by the Atlanta Hawks in the 2014 NBA Draft, Payne came to the Wolves in a February, 2015 trade. For his career, he’s put up per-game averages of 4.1 points and 3.1 rebounds in 96 games, including 24 starts. He last appeared in Minnesota’s loss to Cleveland on February 1st.
Thrombocytopenia has numerous possible causes, ranging from mundane to serious. The fact he’s resting comfortably at home, rather than in a hospital, is hopefully a good sign. From all of us at A Wolf Among Wolves, we wish Adreian a speedy and full recovery.